CURE
OMICS
COMMITTED TO HEALTH
OUR FOCUS
CureOmics is a life science company dedicated to improve therapeutic and preventive options for the treatment of unmet healthcare needs. Our research & development is tailored to create novel pharmaceuticals and specialized food and cosmetics ingredients. Separated from own R&D, the company offers management consulting services to strategic partners.
01 / RESEARCH
Our core mission revolves around pioneering research and development for drug products, specialized food, and cosmetic ingredients. Our team relentlessly pursues innovative solutions that push the boundaries of healthcare. By integrating advanced scientific methodologies, we aim to create products that exceed the highest standards of safety and efficacy.
Our research is centered on healthcare innovation, driving us to explore and develop new therapies and food ingredients that promote health and enhance quality of life. Whether it's formulating breakthrough drug therapies, developing nutritious and functional food ingredients, or creating advanced cosmeceutical products, we are committed to making significant strides towards optimal health. At CureOmics, we believe that through continuous innovation and scientific excellence, we can contribute to a healthier, better world.
02 / PIPELINE
CureOmics' development of drug products and specialized food-supplements employs cutting edge life-science for translating molecular solutions into a pipeline of novel health care options.
For efficient and scalable operations, CureOmics cooperates with established third party partners for formulation development and manufacturing.
03 / CONSULTING
Separated from our research and development operations, we aim to support partners through tailored approaches to create business success. CureOmics' management consulting services for pharmaceutical, nutrition and medicinal product sectors include:
-
Licensing deal & partnering
-
Drug development
-
Marketing strategy
-
GxP and regulatory affairs
CMO & CRO services
CureOmics has entered strategic CRO and CMO partnerships offering with these partners the development of innovative drug products and food supplements.
OUR COMPANY
OUR INSPIRATION
We are committed to bring together the best of science and technology and aim to build breakthrough knowledge.
Our work is inspired by creating complementing solutions for drug innovation & nutrition. We transfer disruptive ideas into tools that support operational evolution and improve success rates.
OUR MISSION
-
Extend the forefront of science
-
Lead innovation beyond existing solutions
-
Employ best technologies
-
Improve healthcare
OUR VISION
Be good and do good
Leadership
Dr. Stebler is the Chief Executive Officer of CureOmics. He has 15 years of experience in the biotechnology and pharmaceutical industry and worked for Kuros Biosurgery, Xeltis, Novartis, and API suppliers. Dr. Stebler is a scientist and economist who has dedicated his career during past years to improve the lives of people with serious diseases. His experience spans clinical and non-clinical research whereas he was also leading teams in business development, GMP manufacturing, regulatory affairs, quality assurance and intellectual property.
Dr. Stebler holds a PhD in Molecular Biology from the Max Planck Institute & University of Göttingen, a MBA from the IE Business School Madrid, a B.Sc. in Chemistry and is certified in Plant-Based Nutrition from the T. Colin Campbell Center for Nutrition Studies. His executive educations in Decision Analysis from Stanford University and Digital Business Strategy from the Massachusetts Institute of Technology will additionally serve CureOmics to achieve the strategic and operational objectives.
DR. JÜRG STEBLER, MBA
CEO
GET IN TOUCH
Office Switzerland
General-Guisan-Strasse 6
6300 Zug
Switzerland